MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells

Huang,Bo; Luo,Wenting; Sun,Limei; Zhang,Qingfu; Jiang,Lili; Chang,Jihong; Qiu,Xueshan; Wang,Enhua

doi:10.3892/ijo.2013.1861

MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells

Authors:
- Bo Huang
- Wenting Luo
- Limei Sun
- Qingfu Zhang
- Lili Jiang
- Jihong Chang
- Xueshan Qiu
- Enhua Wang
View Affiliations

Affiliations: Department of Pathology, First Affiliated Hospital and College of Basic Medical Sciences, China Medical University, Heping, Shenyang, Liaoning 110001, P.R. China
Published online on: March 21, 2013 https://doi.org/10.3892/ijo.2013.1861
Pages: 1734-1742

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNAs (miRNAs) function as genetic modulators that regulate gene expression, and are, thus, involved in a wide range of biological roles, including tumor cell migration and invasion. MiR-125a-3p is a mature form of miR-125a, derived from the 3'-end of pre-miR-125a. Our group has previously reported that miR-125a-3p functions as a tumor suppressor gene that inhibits the migration and invasion of lung cancer cells. Here, we report the discovery of a new regulatory layer of the RhoA-actomyosin pathway through which miR-125a-3p controls tumor cell migration. Overexpression of miR-125a-3p by transfection of sense‑miR‑125a-3p resulted in decreased RhoA protein levels, while the levels of RhoA mRNA remained constant. The concentrations of both RhoA-GTP protein and actin filaments decreased after miR-125a-3p overexpression in the A549 lung cancer cell line. Conversely, knockdown of miR-125a-3p by transfection of antisense-miR-125a-3p resulted in increased RhoA protein levels while the levels of RhoA mRNA remained unchanged. However, the concentration of both RhoA-GTP protein and actin filaments increased. To further demonstrate that RhoA is a potential target of miR‑125a-3p, luciferase reporter constructs containing the RhoA 3'UTR demonstrated reduced reporter activity after ectopic expression of miR-125a-3p. Moreover, luciferase reporter constructs containing the RhoA 3'UTR mutant did not show significantly changed reporter activity. Furthermore, A549 cells demonstrated reduced migratory capacity after treatment with the Rho inhibitor CT04. Our results indicate that the loss of miR-125a‑3p-controlled regulation of the RhoA-actomyosin pathway can lead to increased migration of tumor cells because of the upregulation of RhoA expression. In particular, an increased intracellular concentration of RhoA-GTP protein in A549 cells leads to the accumulation of actin filaments. These results provide new insights into the role of the miR-125a family in lung cancer.

View Figures

View References

1.	Sporn MB: The war on cancer. Lancet. 347:1377–1381. 1996. View Article : Google Scholar : PubMed/NCBI
2.	Nguyen DX, Bos PD and Massague J: Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 9:274–284. 2009. View Article : Google Scholar : PubMed/NCBI
3.	Crawford M, Brawner E, Batte K, et al: MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun. 373:607–612. 2008. View Article : Google Scholar : PubMed/NCBI
4.	Xiong BH, Cheng Y, Ma L and Zhang CQ: Mir-21 regulates biological behavior through the PTEN/PI3K/AKT signaling pathway in human colorectal cancer cells. Int J Oncol. 42:219–228. 2013.PubMed/NCBI
5.	Tavazoie SF, Alarcón C, Oskarsson T, et al: Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 451:147–152. 2008. View Article : Google Scholar : PubMed/NCBI
6.	Nicoloso MS, Spizzo R, Shimizu M, et al: MicroRNAs - the micro steering wheel of tumour metastases. Nat Rev Cancer. 9:293–302. 2009. View Article : Google Scholar : PubMed/NCBI
7.	Valastyan S, Reinhardt F, Benaich N, et al: A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell. 137:1032–1046. 2009. View Article : Google Scholar : PubMed/NCBI
8.	Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
9.	Asangani IA, Rasheed SA, Nikolova DA, et al: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar : PubMed/NCBI
10.	He XY, Chen JX and Zhang Z: The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice. J Cancer Res Clin Oncol. 136:1023–1028. 2010. View Article : Google Scholar : PubMed/NCBI
11.	Wu L and Belasco JG: Micro-RNA regulation of the mammalian lin-28 gene during neuronal differentiation of embryonal carcinoma cells. Mol Cell Biol. 25:9198–9208. 2005. View Article : Google Scholar : PubMed/NCBI
12.	Laneve P, Di Marcotullio L, Gioia U, et al: The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells. Proc Natl Acad Sci USA. 104:7957–7962. 2007. View Article : Google Scholar
13.	Cowden Dahl KD, Dahl R, Kruichak JN, et al: The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells. Neoplasia. 11:1208–1215. 2009.PubMed/NCBI
14.	Jiang L, Huang Q, Zhang S, et al: Hsa-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. BMC Cancer. 10:3182010. View Article : Google Scholar : PubMed/NCBI
15.	Chambers AF, Groom AC and MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2:563–572. 2002. View Article : Google Scholar : PubMed/NCBI
16.	Woodhouse EC, Chuaqui RF and Liotta LA: General mechanisms of metastasis. Cancer. 80(Suppl 8): 1529–1537. 1997. View Article : Google Scholar : PubMed/NCBI
17.	Ho TT, Merajver SD, Lapiere CM, et al: RhoA-GDP regulates RhoB protein stability. J Biol Chem. 283:21588–21598. 2008. View Article : Google Scholar : PubMed/NCBI
18.	Ming J, Liu N, Gu Y, et al: PRL-3 facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A/C in lung cancer. Pathology. 41:118–126. 2009. View Article : Google Scholar : PubMed/NCBI
19.	Etienne-Manneville S and Hall A: Rho GTPases in cell biology. Nature. 420:629–635. 2002. View Article : Google Scholar
20.	Yoshioka K, Matsumura F and Akedo H: Small GTP-binding protein Rho stimulates the actomyosin system, leading to invasion of tumor cells. J Biol Chem. 273:5146–5154. 1998. View Article : Google Scholar : PubMed/NCBI
21.	Paterson HF, Self AJ, Garrett MD, et al: Microinjection of recombinant p21rho induces rapid changes in cell morphology. J Cell Biol. 111:1001–1007. 1990. View Article : Google Scholar : PubMed/NCBI
22.	Takaishi K, Kikuchi A, Kuroda S, et al: Involvement of rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI) in cell motility. Mol Cell Biol. 13:72–79. 1993.PubMed/NCBI
23.	Kishi K, Sasaki T, Kuroda S, et al: Regulation of cytoplasmic division of Xenopus embryo by rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI). J Cell Biol. 120:1187–1195. 1993.PubMed/NCBI
24.	Mabuchi I, Hamaguchi Y, Fujimoto H, et al: A rho-like protein is involved in the organisation of the contractile ring in dividing sand dollar eggs. Zygote. 1:325–331. 1993. View Article : Google Scholar : PubMed/NCBI
25.	Perona R, Esteve P, Jimenez B, et al: Tumorigenic activity of rho genes from Aplysia californica. Oncogene. 8:1285–1292. 1993.PubMed/NCBI
26.	Prendergast GC, Khosravi-Far R, Solski P, et al: Critical role of Rho in cell transformation by oncogenic Ras. Oncogene. 10:2289–2296. 1995.PubMed/NCBI
27.	Fritz G, Just I and Kaina B: Rho GTPases were over-expressed in human tumors. Int J Cancer. 81:682–687. 1990. View Article : Google Scholar
28.	Horiuchi A, Kikuchi N, Osada R, et al: Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with Lovastatin may be useful for ovarian cancer. Cancer Sci. 12:2532–2539. 2008. View Article : Google Scholar : PubMed/NCBI
29.	Yoshioka K, Nakamori S and Itoh K: Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells. Cancer Res. 59:2004–2010. 1999.PubMed/NCBI